- Corporate Officers - A
- Andrews Ronald Asbury
Insider Trading History of Andrews Ronald Asbury
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Andrews Ronald Asbury since 2005.
This trader's CIK number is 1299153.
At the time of last reporting, Andrews Ronald Asbury was the Former CEO of Oncocyte Corp. (stock ticker symbol OCX).
Also see all insider trading activities at Oncocyte Corp.
Note that in the past
ANDREWS RONALD ASBURY also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Cardiac Science Corp (CSCX) by Andrews Ronald Asbury
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | CSCX | 0 | $0 | 0 | $0 | 3,000 | $0 |
Yearly summary of insider trading at Oncocyte Corp (OCX) by Andrews Ronald Asbury
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | OCX | 90,000 | $102,549 | 0 | $0 | 250,000 | $0 |
| 2021 | OCX | 11,000 | $52,701 | 0 | $0 | 65,000 | $0 |
| 2020 | OCX | 85,216 | $42,811,333 | 0 | $0 | 0 | $0 |
| 2018 | OCX | 17,482 | $0 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Chromavision Medical Systems Inc (CLRT) by Andrews Ronald Asbury
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | CLRT | 12,000 | $28,920 | 0 | $0 | 0 | $0 |
| 2008 | CLRT | 7,500 | $14,505 | 0 | $0 | 0 | $0 |
| 2007 | CLRT | 5,000 | $9,600 | 0 | $0 | 0 | $0 |
| 2005 | CLRT | 28,000 | $37,134 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Invitrogen Corp (LIFE) by Andrews Ronald Asbury
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | LIFE | 0 | $0 | 0 | $0 | 6,639 | $434,692 |
| 2012 | LIFE | 3,330 | $154,815 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Andrews Ronald Asbury:
1. Cardiac Science Corp (CSCX)
2. Oncocyte Corp (OCX)
3. Chromavision Medical Systems Inc (CLRT)
4. Invitrogen Corp (LIFE)
Table 1. Insider trading of Cardiac Science Corp (CSCX) by Andrews Ronald Asbury
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-11-05 | CSCX | Option Ex | 1,000 | .00 | 0 |
| 2010-11-05 | CSCX | Option Ex | 1,000 | .00 | 0 |
| 2010-11-05 | CSCX | Option Ex | 1,000 | .00 | 0 |
Table 2. Insider trading of Oncocyte Corp (OCX) by Andrews Ronald Asbury
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-12-01 | OCX | Option Ex | 250,000 | .00 | 0 |
| 2022-08-16 | OCX | Buy | 40,000 | .96 | 38,400 |
| 2022-03-16 | OCX | Buy | 50,000 | 1.28 | 64,149 |
| 2021-07-01 | OCX | Option Ex | 65,000 | .00 | 0 |
| 2021-03-19 | OCX | Buy | 11,000 | 4.79 | 52,701 |
| 2020-08-03 | OCX | Buy | 40,000 | 1.35 | 53,880 |
| 2020-03-30 | OCX | Buy | 27,216 | 2.26 | 61,453 |
| 2020-03-31 | OCX | Buy | 18,000 | 2,372.00 | 42,696,000 |
| 2018-07-26 | OCX | Buy | 17,482 | .00 | 0 |
Table 3. Insider trading of Chromavision Medical Systems Inc (CLRT) by Andrews Ronald Asbury
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-03-12 | CLRT | Buy | 12,000 | 2.41 | 28,920 |
| 2008-09-18 | CLRT | Buy | 7,500 | 1.93 | 14,505 |
| 2007-05-07 | CLRT | Buy | 5,000 | 1.92 | 9,600 |
| 2005-11-14 | CLRT | Buy | 10,000 | 1.19 | 11,880 |
| 2005-06-10 | CLRT | Buy | 18,000 | 1.40 | 25,254 |
Table 4. Insider trading of Invitrogen Corp (LIFE) by Andrews Ronald Asbury
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-04-02 | LIFE | Option Ex | 3,067 | 65.75 | 201,655 |
| 2013-02-01 | LIFE | Option Ex | 3,572 | 65.24 | 233,037 |
| 2012-04-27 | LIFE | Buy | 3,330 | 46.49 | 154,815 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Andrews Ronald Asbury
(Former CEO of Oncocyte Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.